C-reactive protein and angiographic characteristics of stable and unstable coronary artery disease: Data from the prospective PREVEND cohort

Atherosclerosis

Volumn 196, Issue 1, 2008, Pages 372-382

  Geluk, Christiane A ^a   Post, Wendy J ^a   Hillege, Hans L ^a   Tio, René A ^a   Tijssen, Jan G P ^b   van Dijk, René B ^c   Arnold Dijk, W ^a   Bakker, Stephan J L ^a   de Jong, Paul E ^a   van Gilst, Wiek H ^a   Zijlstra, Felix ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c MARTINI HOSPITAL   (Netherlands)

Author keywords

Coronary angiography; CRP; Plaque morphology; Risk factors; Unstable plaque

Indexed keywords

C REACTIVE PROTEIN; LIPID;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BLOOD PRESSURE; COHORT ANALYSIS; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORONARY BLOOD VESSEL; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; SEX DIFFERENCE; SMOKING;

AGED; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; CORONARY OCCLUSION; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES;

EID: 38049018480     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2006.11.013     Document Type: Article

References (38)

1. Danesh J., Wheeler J.G., Hirschfield G.M., et al. C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease. N Engl J Med 350 14 (2004) 1387-1397
2. Zairis M.N., Papadaki O.A., Manousakis S.J., et al. C-reactive protein and multiple complex coronary artery plaques in patients with primary unstable angina. Atherosclerosis 164 2 (2002) 355-359
3. Lindahl B., Toss H., Siegbahn A., Venge P., and Wallentin L. Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. FRISC Study Group. Fragmin during Instability in Coronary Artery Disease. N Engl J Med 343 16 (2000) 1139-1147
4. Zebrack J.S., Muhlestein J.B., Horne B.D., and Anderson J.L. C-reactive protein and angiographic coronary artery disease: independent and additive predictors of risk in subjects with angina. J Am Coll Cardiol 39 4 (2002) 632-637
5. Arroyo-Espliguero R., Avanzas P., Cosin-Sales J., et al. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 25 5 (2004) 401-408
6. Katritsis D., Korovesis S., Giazitzoglou E., et al. C-Reactive protein concentrations and angiographic characteristics of coronary lesions. Clin Chem 47 5 (2001) 882-886
7. Goldstein J.A., Demetriou D., Grines C.L., et al. Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med 343 13 (2000) 915-922
8. Burke A.P., Tracy R.P., Kolodgie F., et al. Elevated C-reactive protein values and atherosclerosis in sudden coronary death: association with different pathologies. Circulation 105 17 (2002) 2019-2023
9. Jialal I., Devaraj S., and Singh U. C-reactive protein and the vascular endothelium: implications for plaque instability. J Am Coll Cardiol 47 7 (2006) 1379-1381
10. Taylor K.E., Giddings J.C., and van den Berg C.W. C-reactive protein-induced in vitro endothelial cell activation is an artefact caused by azide and lipopolysaccharide. Arterioscler Thromb Vasc Biol 25 6 (2005) 1225-1230
11. Azar R.R., Aoun G., Fram D.B., et al. Relation of C-reactive protein to extent and severity of coronary narrowing in patients with stable angina pectoris or abnormal exercise tests. Am J Cardiol 86 2 (2000) 205-207
12. Avanzas P., Arroyo-Espliguero R., Cosin-Sales J., et al. Multiple complex stenoses, high neutrophil count and C-reactive protein levels in patients with chronic stable angina. Atherosclerosis 175 1 (2004) 151-157
13. Avanzas P., Arroyo-Espliguero R., Cosin-Sales J., et al. Markers of inflammation and multiple complex stenoses (pancoronary plaque vulnerability) in patients with non-ST segment elevation acute coronary syndromes. Heart 90 8 (2004) 847-852
14. Zairis M.N., Lyras A.G., Bibis G.P., et al. Association of inflammatory biomarkers and cardiac troponin I with multifocal activation of coronary artery tree in the setting of non-ST-elevation acute myocardial infarction. Atherosclerosis 182 1 (2005) 161-167
15. Smilde T.D., Asselbergs F.W., Hillege H.L., et al. Mild renal dysfunction is associated with electrocardiographic left ventricular hypertrophy. Am J Hypertens 18 3 (2005) 342-347
16. Bertrand M.E., Simoons M.L., Fox K.A., et al. Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Eur Heart J 23 23 (2002) 1809-1840
17. Van de Werf F., Ardissino D., Betriu A., et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of Acute Myocardial Infarction of the European Society of Cardiology. Eur Heart J 24 1 (2003) 28-66
18. Pearson T.A., Mensah G.A., Alexander R.W., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice-a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 3 (2003) 499-511
19. Koenig W., Sund M., Frohlich M., et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 2 (1999) 237-242
20. Ridker P.M., Cushman M., Stampfer M.J., Tracy R.P., and Hennekens C.H. Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men. N Engl J Med 336 14 (1997) 973-979
21. Ridker P.M., Hennekens C.H., Buring J.E., and Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342 12 (2000) 836-843
22. Ridker P.M., Buring J.E., Cook N.R., and Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14719 initially healthy American women. Circulation 107 3 (2003) 391-397
23. Kaski J.C., and Cox I.D. Chronic infection and atherogenesis. Eur Heart J 19 3 (1998) 366-367
24. Fuster V., Moreno P.R., Fayad Z.A., Corti R., and Badimon J.J. Atherothrombosis and high-risk plaque. Part I: evolving concepts. J Am Coll Cardiol 46 6 (2005) 937-954
25. Montero I., Orbe J., Varo N., et al. C-reactive protein induces matrix metalloproteinase-1 and -10 in human endothelial cells: implications for clinical and subclinical atherosclerosis. J Am Coll Cardiol 47 7 (2006) 1369-1378
26. Zwaka T.P., Hombach V., and Torzewski J. C-reactive protein-mediated low density lipoprotein uptake by macrophages: implications for atherosclerosis. Circulation 103 9 (2001) 1194-1197
27. Zouridakis E., Avanzas P., Arroyo-Espliguero R., Fredericks S., and Kaski J.C. Markers of inflammation and rapid coronary artery disease progression in patients with stable angina pectoris. Circulation 110 13 (2004) 1747-1753
28. Hill A.B. THE environment and disease: association or causation?. Proc R Soc Med 58 (1965) 295-300
29. Ray K.K., Cannon C.P., Cairns R., et al. Relationship between uncontrolled risk factors and C-reactive protein levels in patients receiving standard or intensive statin therapy for acute coronary syndromes in the PROVE IT-TIMI 22 trial. J Am Coll Cardiol 46 8 (2005) 1417-1424
30. de Lemos J.A., Blazing M.A., Wiviott S.D., et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial. JAMA 292 11 (2004) 1307-1316
31. Burke A.P., Farb A., Malcom G.T., et al. Plaque rupture and sudden death related to exertion in men with coronary artery disease. JAMA 281 10 (1999) 921-926
32. Burke A.P., Farb A., Malcom G.T., et al. Coronary risk factors and plaque morphology in men with coronary disease who died suddenly. N Engl J Med 336 18 (1997) 1276-1282
33. Rioufol G., Finet G., Ginon I., et al. Multiple atherosclerotic plaque rupture in acute coronary syndrome: a three-vessel intravascular ultrasound study. Circulation 106 7 (2002) 804-808
34. Maehara A., Mintz G.S., Bui A.B., et al. Morphologic and angiographic features of coronary plaque rupture detected by intravascular ultrasound. J Am Coll Cardiol 40 5 (2002) 904-910
35. Rittersma S.Z., van der Wal A.C., Koch K.T., et al. Plaque instability frequently occurs days or weeks before occlusive coronary thrombosis: a pathological thrombectomy study in primary percutaneous coronary intervention. Circulation 111 9 (2005) 1160-1165
36. Burke A.P., Kolodgie F.D., Farb A., et al. Healed plaque ruptures and sudden coronary death: evidence that subclinical rupture has a role in plaque progression. Circulation 103 7 (2001) 934-940
37. Casscells W., Naghavi M., and Willerson J.T. Vulnerable atherosclerotic plaque: a multifocal disease. Circulation 107 16 (2003) 2072-2075
38. Proudfit W.J., Bruschke A.V., MacMillan J.P., Williams G.W., and Sones Jr. F.M. Fifteen year survival study of patients with obstructive coronary artery disease. Circulation 68 5 (1983) 986-997